. . "rheumatoid arthritis; tofacitinib; adalimumab"@en . "Tofacitinib or adalimumab versus placebo in rheumatoid arthritis: Commentary to the study"@en . "RIV/00023728:_____/12:#0002063" . . "3"^^ . . . . "Tofacitinib nebo adalimumab vs. Placebo v l\u00E9\u010Db\u011B revmatoidn\u00ED artritidy - studie ORAL Standard : komen\u00E1\u0159 ke studii"@cs . "174564" . "Tofacitinib or adalimumab versus placebo in rheumatoid arthritis: Commentary to the study"@en . "V \u010Dl\u00E1nku jsou komentov\u00E1ny v\u00FDsledky studie t\u00FDkaj\u00EDc\u00ED se l\u00E9\u010Dby tofacitinibem nebo adalimumabem v porovn\u00E1n\u00ED s placebem u pacient\u016F s revmatoidn\u00ED artritidou, kde selhala l\u00E9\u010Dba metotrex\u00E1tem." . . . . "6" . "RIV/00023728:_____/12:#0002063!RIV13-MZ0-00023728" . "V" . "Tofacitinib nebo adalimumab vs. Placebo v l\u00E9\u010Db\u011B revmatoidn\u00ED artritidy - studie ORAL Standard : komen\u00E1\u0159 ke studii" . . . "V \u010Dl\u00E1nku jsou komentov\u00E1ny v\u00FDsledky studie t\u00FDkaj\u00EDc\u00ED se l\u00E9\u010Dby tofacitinibem nebo adalimumabem v porovn\u00E1n\u00ED s placebem u pacient\u016F s revmatoidn\u00ED artritidou, kde selhala l\u00E9\u010Dba metotrex\u00E1tem."@cs . "Tofacitinib nebo adalimumab vs. Placebo v l\u00E9\u010Db\u011B revmatoidn\u00ED artritidy - studie ORAL Standard : komen\u00E1\u0159 ke studii" . "Tofacitinib nebo adalimumab vs. Placebo v l\u00E9\u010Db\u011B revmatoidn\u00ED artritidy - studie ORAL Standard : komen\u00E1\u0159 ke studii"@cs . "Farmakoterapie" . . "8" . "1801-1209" . "In the article are commentes results of the study with tofacitinib or adalimumab compare to placebo in the metotrexate-failure patients with rheumatoid arthritis."@en . "Forejtov\u00E1, \u0160\u00E1rka" . . . "1"^^ . "[59165A5108AE]" . . "1"^^ . "CZ - \u010Cesk\u00E1 republika" .